S-EPMC8849383 - Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies. - OmicsDI

Unknown

Dataset Information

Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies.

ABSTRACT:

SUBMITTER: Petzer V

PROVIDER: S-EPMC8849383 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature